Showing results (321-330 of 443) with videos related to
Sort By:
Pageof 45
Oncotarget|June 2, 2015
High mesothelin expression in advanced lung adenocarcinoma is associated with KRAS mutations and a poor prognosisAnish Thomas, Yuanbin Chen, Seth M Steinberg, et al.Cancer Research|November 3, 2006
Eradication of tumor colonization and invasion by a B cell-specific immunotoxin in a murine model for human primary intraocular lymphomaZhuqing Li, Sankaranarayana P Mahesh, De Fen Shen, et al.Molecular Cancer Therapeutics|April 8, 2010
Interstitial infusion of glioma-targeted recombinant immunotoxin 8H9scFv-PE38Neal Luther, Nai-Kong Cheung, Eleni P Souliopoulos, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|June 27, 2012
Pulsed high intensity focused ultrasound increases penetration and therapeutic efficacy of monoclonal antibodies in murine xenograft tumorsShutao Wang, In Soo Shin, Hilary Hancock, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 5, 2006
Characterization of the B cell epitopes associated with a truncated form of Pseudomonas exotoxin (PE38) used to make immunotoxins for the treatment of cancer patientsMasanori Onda, Satoshi Nagata, David J FitzGerald, et al.Science Translational Medicine|October 25, 2013
Major cancer regressions in mesothelioma after treatment with an anti-mesothelin immunotoxin and immune suppressionRaffit Hassan, Andrew C Miller, Elad Sharon, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2007
Administration of a CD25-directed immunotoxin, LMB-2, to patients with metastatic melanoma induces a selective partial reduction in regulatory T cells in vivoDaniel J Powell, Aloisio Felipe-Silva, Maria J Merino, et al.Science Translational Medicine|July 3, 2020
Enhanced efficacy of mesothelin-targeted immunotoxin LMB-100 and anti-PD-1 antibody in patients with mesothelioma and mouse tumor modelsQun Jiang, Azam Ghafoor, Idrees Mian, et al.Proceedings of the National Academy of Sciences of the United States of America|December 19, 2012
Systemic administration of a bispecific antibody targeting EGFRvIII successfully treats intracerebral gliomaBryan D Choi, Chien-Tsun Kuan, Mingqing Cai, et al.Proceedings of the National Academy of Sciences of the United States of America|April 6, 2006
High expression of a cytokeratin-associated protein in many cancersKristi A Egland, Xiu Fen Liu, Stephen Squires, et al.Pageof 45